[Federal Register Volume 63, Number 145 (Wednesday, July 29, 1998)]
[Notices]
[Page 40529]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-20221]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting.
Name: Disease, Disability, and Injury Prevention and Control
Special Emphasis Panel (SEP): Cooperative Agreements for Measuring
the Risk for Transmittal and Sequelae from Chlamydial Disease in the
Era of Amplification Testing, Program Announcement # 98094, meeting.
Times and Dates: 8:30-9 a.m., September 8, 1998 (Open); 9 a.m.-
4:30 p.m., September 8, 1998 (Closed); 9 a.m-4:30 p.m., September 9,
1998 (Closed); 9 a.m.-4:30 p.m., September 10, 1998 (Closed).
Place: National Center for HIV, STD, and TB Prevention, CDC,
Corporate Square Office Park, Building 10, DQ Conference Room,
Atlanta, Georgia 30329.
Status: Portions of the meeting will be closed to the public in
accordance with provisions set forth in section 552b(c)(4) and (6),
Title 5 U.S.C., and the Determination of the Associate Director for
Management and Operations, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the review,
discussion, and evaluation of applications received in response to
Program Announcement # 98094.
Contact Person for More Information: John R. Lehnnherr, Chief,
Prevention Support Office, National Center for HIV, STD, and TB
Prevention, CDC, Corporate Square Office Park, 11 Corporate Square
Boulevard, M/S E07, Atlanta, Georgia 30329, telephone 404/639-8025.
Dated: July 23, 1998.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention CDC.
[FR Doc. 98-20221 Filed 7-28-98; 8:45 am]
BILLING CODE 4163-18-P
